Right. On Time.

At CMC Biologics, doing contract biopharmaceutical development and manufacturing right means offering more than a broad array of high quality services. It means providing solutions that meet client’s manufacturing needs today while positioning them for success tomorrow. Our clients’ commitment to patients inspires each member of the CMC Biologics’ team to do whatever is necessary – not just what is expected – to ensure the success of every project. Our customers know that patients can’t wait. Which is why we get it Right. Every Time.

Photo Tour of Facilities


News & Events


October 22, 2015

CMC Biologics Announces Agreement with Immunocore for Process Transfer, Scale-up and Commercial-Scale Manufacturing of IMCgp100


October 20, 2015

CMC Biologics Announces Appointment of New CEO

October 7, 2015

Governor Inslee’s Director of Life Science and Global Health Development, Maura Little, Presides Over CMC Biologics’ Ribbon Cutting Ceremony Commemorating the Bioreactor 6Pack™ Manufacturing Facility

August 12, 2015

CMC Biologics Enters into Agreement with the PATH Malaria Vaccine Initiative for Accelerated Development and Manufacturing of Monoclonal Antibodies


July 29, 2015

CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave’s Orbitopathy


June 30, 2015

CMC Biologics Expands GMP Manufacturing Capacity in the United States


May 20, 2015

CMC Biologics Expands European GMP Manufacturing Capacity


May 7, 2015

CMC Biologics Expands GMP Manufacturing Capacity in the United States and Europe


May 5, 2015

CMC Biologics in Commercial Supply Agreement with Emergent BioSolutions for FDA-Approved IXINITY®


March 19, 2015

CMC Biologics Recognized for Quality and Reliability at the 2015 CMO Leadership Awards Ceremony


January 30, 2015

Serendex Pharmaceuticals and CMC Biologics Enter Exclusive Agreement on Factor VIIa